Luc Montagnier received the 2008 Nobel Prize in Physiology or Medicine for his discovery of the human immunodeficiency virus (HIV), but now he came up with a more than strange theory. He thinks DNA can teleport from one tube to another via electromagnetic signals. Is this the so-called Nobel-disease?
French virologist Luc Montagnier stunned his colleagues at a prestigious international conference when he presented a new method for detecting viral infections that bore close parallels to the basic tenets of homeopathy.
Although fellow Nobel prize winners — who view homeopathy as quackery — were left openly shaking their heads, Montagnier’s comments were rapidly embraced by homeopaths eager for greater credibility.
Montagnier told the conference last week that solutions containing the DNA of pathogenic bacteria and viruses, including HIV, “could emit low frequency radio waves” that induced surrounding water molecules to become arranged into “nanostructures”. These water molecules, he said, could also emit radio waves
He suggested water could retain such properties even after the original solutions were massively diluted, to the point where the original DNA had effectively vanished. In this way, he suggested, water could retain the “memory” of substances with which it had been in contact — and doctors could use the emissions to detect disease.
This talk will introduce current best practice in biological engineering, including an overview of how to order synthetic DNA and how to use and contribute standard biological parts to an open source collection of genetic functions. The talk will also discuss issues of human practice, including biological safety, biological security, ownership, sharing, and innovation in biotechnology, community organization, and perception across many different publics.
A few months ago, Alexandra Pajak, a graduate student at the University of Georgia contacted me about an album of music based on the DNA of the HIV virus she was about to release. I feel lucky that the album is just on its way to my CD player right now. You can buy the album on Amazon (release date: 26, October). Note that some of the proceeds will go to the Emory Vaccine Center, which conducts research for an HIV vaccine. If you wonder how it was made, here is the explanation:
Sounds of HIV is a musical translation of the genetic code of HIV, the Human Immunodeficiency Virus. Every segment of the virus is assigned music pitches that correspond to the segment’s scientific properties. In this way, the sounds reflect the true nature of the virus. When listening from beginning to end, the listener hears the entire genome of HIV.
In English, the nucleotides Adenine, Cytosine, Uracil/Thymine, and Guanine are abbreviated with the letters A, C, T, and G. Since A, C, and G are also musical pitches in the Western melodic scale, these pitches were assigned to the matching nucleotides. To form two perfect fifths (C-G and D-A), “D” was arbitrarily assigned to musically represent Uracil. I assigned the pitches of the A minor scale to the amino acids based on their level of attraction to water.
On “Sounds of HIV,” depending on the track, only nucleotides and/or amino acids “play” as music. Tracks 1 and 10 are based on the first and last nucleotides of the RNA chain. Tracks 2-9 “play” the proteins and sometimes the nucleotides on top of the proteins.
I would like to share three papers, articles that focus on the personalized genomics market with you. Almost 3 years ago, I wrote about that FDA had suggested two genetic markers to be used to determine the minimal starting dose of Coumadin. Later, in a paper, Rosove et al. said that “The value and cost-effectiveness of genetic testing to reduce bleeding or thrombosis rates remain unknown.”
Patients who received a test of two genes connected to warfarin sensitivity were 28 percent less likely to be hospitalized for a bleeding episode or blood clot than those whose safe and effective warfarin dosing was determined by traditional trial and error method.
“Utilizing a complete map of the molecular changes within a tumour in a clinical setting represents a world first in the application of this technology,” says Dr. Steven Jones, associate director of the Genome Sciences Centre and professor, Simon Fraser University. “It ushers in the era of personalized medicine in oncology, whereby therapies will be tailored precisely to the genetic make-up of the tumour. I anticipate that in the not too distant future nearly all patient tumours will be characterized in this way as a matter of course.”
And Health Populi reported a very interesting correlation between DTC ads, genetic pre-disposition, and healthy decisions:
A team of researchers now finds that DTC can play an important, positive role in motivating health consumers to adopt healthy behaviors. “The intention to engage in healthy lifestyles was strengthened by exposure to familial risk cues in DTC ads and this effect was mediated through enhanced efficacy to take healthy actions,” the paper concludes. Familial risk cues engendered positive self-efficacy.
One of my favourite blogs, Spoonful of Medicine, just posted a great video which shows that mutations in E. coli bacteria can be tracked in real time. The method was published in Current Biology.
The key to this approach is using a fluorescent-labeled derivative of MutL, a protein involved in DNA mismatch repair. The accumulation of this fluorescent protein signals the occurrence of a mutation in a population of replicating E. coli bacteria. Even more significantly, this method allows the visualization of mutations that do not result in recognizable phenotypes. That means that it could be used to alert researchers to DNA errors they are not even looking for. The video below shows 180 minutes of E.coli growth compressed to 12 seconds:
DNA As Crystal Ball: Buyer Beware (Newsweek): A genome-wide association study identified a new gene variant associated with Alzheimer’s disease but it turned out clinically it’s not useful.
“Adding these genes to traditional risk factors, such as age and sex, does nothing to aid prediction” of whether someone will develop Alzheimer’s, she told me. “Knowing your genetic status will not help. We may still be in the Stone Age when it comes to gene-based prediction.”
The United States House of Representatives Committee on Energy and Commerce today launched an investigation into direct-to-consumer (DTC) genetic testing, sending letters to three prominent DTC companies: 23andMe, Pathway Genomics and Navigenics.
The family said they received no medical counseling here and are making their own conclusions. One comment made is that the parents stated they will probably be using more pharmaceuticals, interesting.
“For the first time, microscopic robots made from DNA molecules can walk, follow instructions and work together to assemble simple products on an atomic-scale assembly line, mimicking the machinery of living cells, two independent research teams announced Wednesday.”